Providers stack CJC-1295 and ipamorelin to prompt growth hormone release through two signals instead of one. People look to the pair for goals like faster recovery and more energy, and a provider decides whether it fits.
Why do providers stack CJC-1295 and ipamorelin?
Providers stack CJC-1295 and ipamorelin because each one tells the pituitary, a small gland at the base of the brain, to release growth hormone through a different signal. CJC-1295 copies growth hormone-releasing hormone, and ipamorelin switches on the ghrelin receptor.
Your pituitary releases growth hormone when it receives signals, and two different signals can start that release: one from growth hormone-releasing hormone and one from ghrelin. Each peptide stands in for one of them, so the pair uses both routes instead of one. Neither peptide is growth hormone itself, so both prompt your pituitary to release the hormone it already makes.
What does each peptide do on its own?
Both are peptides, short chains of amino acids that act as signals in the body, and they fall under peptide therapy.
CJC-1295 is a lab-made version of growth hormone-releasing hormone (GHRH), the signal your brain uses to start growth hormone release. It acts on the GHRH receptor in the pituitary, a receptor being the docking point on a cell where a signal fits.
Ipamorelin switches on a different receptor, the ghrelin receptor, which responds to ghrelin, a hormone first identified in the stomach.
Because the two use different receptors, each adds a signal the other does not.
What happens when the two signals work together?
In a 1990 study, healthy men received GHRH (the signal CJC-1295 copies), GHRP (an older peptide that signals the way ipamorelin does), or both. At lower doses of GHRP, the two together released more growth hormone than either did alone.
CJC-1295 and ipamorelin were developed later to send these same two kinds of signal. The 1990 study points to results that the two kinds of signal can add to each other, which is the idea behind pairing them.
CJC-1295 and ipamorelin benefits: what providers track
Studies of each peptide found growth hormone release, in healthy adults for CJC-1295 and in healthy men for ipamorelin. At Dynamis Online, a provider tracks your own labs and goals to see whether the pair is working for you.
If you have been wondering about growth hormone, a provider can check your IGF-1 blood tests to see where you stand. Growth hormone levels change throughout the day. IGF-1 (insulin-like growth factor 1), a blood marker that reflects growth hormone activity, stays steadier, so providers track it.
Over time, a provider can follow three things:
- your IGF-1 level
- your blood sugar control, which growth hormone can affect
- your progress toward the goals you set
How a Dynamis provider decides if the stack fits you
A Dynamis provider decides whether the pair fits you, using your goals, health history, and labs, and checks again after you begin. This is how Dynamis works, in four steps:
- Talk through your goals and health history.
- Check starting levels of your IGF-1 and other hormones.
- Set a plan with your provider, including dose and schedule.
- Work with your coach, with IGF-1 rechecks along the way, and follow-up labs tell your provider whether to hold, adjust or stop.
If your provider decides the pair fits, Dynamis prescribes CJC-1295 and ipamorelin together. Both are compounded, prescription-only peptides given by injection. Read how Dynamis prescribes CJC-1295 and ipamorelin on its treatment page, or see our guide on how compounded peptides are prescribed.
Your Personal Health Coach answers questions by call, text, email, or portal message between provider checks, with a 2-hour response time.
Questions worth bringing to your provider:
- Which blood tests should I have before I start, and how often will we repeat them?
- How will we measure whether this is right for my goals?
- Which of my medications and supplements should you know about?
- How does my coach check in between provider reviews?
If you want to see whether the pair fits your goals, book a kickoff call.